JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 114 filers reported holding JOUNCE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.78 and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $59,679 | +66.7% | 32,259 | 0.0% | 0.02% | +53.3% |
Q4 2022 | $35,807 | -52.3% | 32,259 | 0.0% | 0.02% | -53.1% |
Q3 2022 | $75,000 | -23.5% | 32,259 | 0.0% | 0.03% | -23.8% |
Q2 2022 | $98,000 | -55.3% | 32,259 | 0.0% | 0.04% | -45.5% |
Q1 2022 | $219,000 | -1.4% | 32,259 | +21.4% | 0.08% | +5.5% |
Q4 2021 | $222,000 | +12.1% | 26,582 | -0.4% | 0.07% | +7.4% |
Q3 2021 | $198,000 | +51.1% | 26,684 | +38.8% | 0.07% | +58.1% |
Q2 2021 | $131,000 | -0.8% | 19,221 | +49.6% | 0.04% | -12.2% |
Q1 2021 | $132,000 | – | 12,844 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP II, LLC | 2,697,829 | $22,527,000 | 93.16% |
TRV GP III, LLC | 1,148,780 | $9,592,000 | 2.40% |
Deep Track Capital, LP | 4,000,000 | $33,400,000 | 2.36% |
Ally Bridge Group (NY) LLC | 575,000 | $4,801,000 | 1.68% |
Logos Global Management LP | 1,350,000 | $11,273,000 | 1.16% |
PFM Health Sciences, LP | 3,972,868 | $33,173,000 | 1.13% |
SILVERARC CAPITAL MANAGEMENT, LLC | 245,829 | $2,053,000 | 0.83% |
Yorktown Management & Research Co Inc | 137,300 | $1,146,000 | 0.77% |
Sofinnova Investments, Inc. | 1,582,777 | $13,216,000 | 0.77% |
ACUTA CAPITAL PARTNERS, LLC | 127,500 | $1,065,000 | 0.45% |